In 2006 China approved 6500 new drugs - the US approved approx. 100. Accidents and even deaths from disqualified drugs has created political interest in China who are calling for stiffer punishments and better safety procedures.

The dismissal of the director of the SFDA for taking bribes for allowing the release of drugs without full safety precautions only highlights the depth of the problem.  Stiff competition creates the need for lower costs - however they can be achieved.